Voice assistant technology poised to fundamentally transform clinical research

Monday, November 13, 2017

Within the next five to 10 years, patients enrolled in research studies will using voice assistant technology such as Amazon Alexa or Google Assistant to interact with clinical trials. Experts expect that these voice assist devices will bolster patient engagement, and may eventually streamline the research enterprise for sponsors and site coordinators as well. On Wednesday, November 8, ICON demonstrated Amazon Alexa’s capacity to deploy a commonly used research questionnaire at the ISPOR 20th Annual European Congress in Glasgow, Scotland. According to Muehlhausen, controlled studies are “the next step” for ICON. “We have a pharma company that has already committed to run a scientific exercise in which we’ll compare Alexa versus an IVR system or a paper system.”

[Read More]

Insys Therapeutics founder arrested on charges of racketeering

Monday, November 6, 2017

On the very same day President Donald Trump declared the opioid crisis to be a nationwide public health emergency, Insys Therapeutics founder and majority owner John Kapoor was arrested. He was charged with leading a nationwide conspiracy to profit by using bribes and fraud to cause the illegal distribution of his company’s Fentanyl spray, Subsys, intended for cancer patients experiencing breakthrough pain. 

[Read More]

Integrated delivery of CRO services

Friday, September 1, 2017

Unified delivery of a broad range of services by a CRO within a single clinical trial can be difficult to do as each role within a CRO—be it a Clinical, Data or Laboratory Project Manager, is primarily focused on delivery of their own aspects of the trial.

[Read More]

New EU medical device regulations cause industry shake up

Monday, August 21, 2017

Medical device manufacturers will need to provide substantially more clinical evidence to support claims of safety and performance for many medical and in vitro diagnostic (IVD) devices marketed in the European Union (EU) as the result of two new regulations adopted by the European Parliament.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

Preparing sites for post-acquisition integration

Tuesday, August 1, 2017

The seemingly endless number of tasks required to sell a clinical research site often means there isn’t enough attention focused on what happens after the deal closes. Successful post-acquisition integration can be one of the most challenging, yet important, parts of an M&A process.

[Read More]

ICON acquires Mapi Group

Monday, July 31, 2017

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has acquired the Mapi Group, a Patient-Centered Health Outcomes Research and Commercialization company.

[Read More]